Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.39 USD -2% Market Closed
Market Cap: 163.5m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Skye Bioscience Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Operating Expenses
-$43.3m
CAGR 3-Years
-89%
CAGR 5-Years
-50%
CAGR 10-Years
-79%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.4B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.9B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.8B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Skye Bioscience Inc's Operating Expenses?
Operating Expenses
-43.3m USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Operating Expenses amounts to -43.3m USD.

What is Skye Bioscience Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-79%

Over the last year, the Operating Expenses growth was -259%. The average annual Operating Expenses growth rates for Skye Bioscience Inc have been -89% over the past three years , -50% over the past five years , and -79% over the past ten years .

Back to Top